Navigation Links
Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
Date:3/31/2008

SAN DIEGO, March 31 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company has begun a pivotal U.S. clinical trial of its investigational APTIMA(R) assay to detect human papillomavirus (HPV), which causes cervical cancer.

"Starting this highly complex, multi-center study was an important goal for Gen-Probe in early 2008," said Carl Hull, the Company's president and chief operating officer. "Enrolling our first patient last week is a testament to the hard work of our integrated product development team. We expect that their extensive efforts to date will ultimately result in the introduction of a highly accurate APTIMA HPV assay that improves the detection and treatment of cervical cancer."

The investigational APTIMA HPV assay is an amplified nucleic acid test that detects 14 high-risk HPV types that are associated with cervical cancer. More specifically, the assay detects two messenger RNAs (mRNAs), E6 and E7, that are made in higher amounts when HPV infections progress toward cervical cancer. Gen-Probe believes that targeting these mRNAs may more accurately identify women at higher risk of having, or developing, cervical cancer than competing assays that target HPV DNA. Detecting HPV DNA identifies women who are infected, but HPV infections are common and many resolve without causing cervical cancer.

Women undergoing routine Pap testing at participating U.S. clinics are eligible to participate in the clinical study, which includes two arms. One arm enrolls women whose Pap results are classified as ASC-US (atypical squamous cells of undetermined significance), meaning they are neither normal nor clearly indicative of changes associated with progression to cervical cancer. In t
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
4. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
5. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
6. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
7. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
8. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
11. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)...  Royal Philips (NYSE: PHG AEX: ... ASTRO,s 56th Annual Meeting in San ... confidence, consistency and accuracy in cancer treatment. Producing quality ... radiation oncology solutions underscore Philips, dedication to leading healthcare ... medicine. "Philips is leveraging our expertise in ...
(Date:9/12/2014)... , Sept. 12, 2014  WellStar Paulding Hospital is ... and became the second in the U.S. to offer ... part of WellStar Health System, Paulding Hospital is on ... latest treatments and solutions. Inspire Therapy offers ... patients who are unable to use traditional treatments, like ...
(Date:9/12/2014)... , September 12, 2014 According ... Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac ... Monitoring), Over the Counter & Prescription Based - Global ... global POC Diagnostics Market over the forecast period of ... at a CAGR of 9.3% from 2013 to 2018, ...
Breaking Medicine Technology:Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 2Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 3WellStar Pioneers New Sleep Apnea Treatment 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 3Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 4
... 18, 2011 SomaLogic, Inc., announced today that it ... to use its unique proprietary proteomics technology to accelerate ... "We are excited by this opportunity to work with ... validate novel drug targets, and even develop companion clinical ...
... 2011 Hologic ... ), a leading developer, manufacturer and supplier of premium diagnostics ... the healthcare needs of women, announced today that the U.S. ... Trident specimen radiography system. The system uses Hologic,s proprietary ...
Cached Medicine Technology:SomaLogic Announces Research Agreement with Leading Global Pharmaceutical Company to Accelerate Pharmaceutical Discovery and Development 2FDA Clears Hologic's Specimen Radiography System 2FDA Clears Hologic's Specimen Radiography System 3FDA Clears Hologic's Specimen Radiography System 4
(Date:9/15/2014)... 2014 Marlton, New Jersey, Sept 9, ... M. Goldstein, of the law firm of Ricci Tyrrell ... the issuance of U.S. Patent No. 8,774,911 from the ... innovative design for a pedicle locator instrument is invented ... a board certified neurosurgeon specializing in minimally-invasive spine surgery. ...
(Date:9/15/2014)... Fancyflyingfox.com, the distinguished wedding dress manufacturer and retailer, ... wedding dresses . All clients can enjoy a greatly ... to 70 percent off. According to the company’s sales ... loyal customers by launching the current sale. , ... different styles of special occasion gowns are provided. All ...
(Date:9/14/2014)... This event allowed the participants to rehearse cooking for ... Social Gastronomy which will be held on 9 October ... bring together a total of 90 participants comprising 30 ... 30 disadvantaged families, forming 30 teams to prepare a ... raise the public’s awareness of reducing food waste, as ...
(Date:9/14/2014)... Proper oral care requires about two minutes ... a way to teach children to brush their teeth ... encourages an effective brushing habit by ensuring that he ... overbrushing, eliminating guesswork and promoting independence and proper oral ... for all children, and producible in design variations. , ...
(Date:9/14/2014)... Transvaginal mesh ( http://www.injurybeacon.com/transvaginal-mesh/ ) lawsuits ... two separate litigations are moving forward in Atlantic County ... to Case Lists updated on September 5th, thousands of ... C.R. Bard Inc., and Johnson & Johnson’s Ethicon unit. ... a total of 1,557 claims have now been filed, ...
Breaking Medicine News(10 mins):Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 3Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 4Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 5Health News:Great Discounts On Beach Wedding Dresses Announced By Fancyflyingfox.com Now 2Health News:PolyU Invites Professional Chefs and Grassroot Families to Prepare a Feast Using Unwanted Fresh Food Collected from Local Wet Markets 2Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 2Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 3Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 4
... job strain, long hours to low birth weight , THURSDAY, ... increases the risk of low infant birth weight, a new ... women who filled out a questionnaire on employment and working ... 32 hours or more and high job strain during the ...
... out you,re not alone." , , ARLINGTON, Va., June ... released "Puzzle Pieces," a new public service announcement (PSA) initiative ... to help themselves, their families and their friends who live ... five American families is affected by mental illnesses such as ...
... St. Charles Surgical Hospital (SCSH) ... develop a dedicated and comprehensive lymphedema treatment program complete with trained ... Scott Sullivan and Frank DellaCroce , principal surgeons ... Breast Surgery , have created the first program of its ...
... Hospital for Children ... some things in life are still free thanks to Cox Communications. ... Van Dyck Park in Fairfax, the company hosts its annual ... offering family-friendly entertainment under the stars. This is the seventh ...
... American Indians, Hispanics were most vulnerable, report shows , ... of people who take their own lives are intoxicated ... , From 2001 to 2005, there were an estimated ... those deaths were associated with suicide, according to the ...
... ... ranked among America,s best pediatric institutions by U.S. News & World Report. Children,s ... in eight pediatric subspecialty areas. Ranked in the top 30 of nearly 100 ... their families for more than 135 years. , ...
Cached Medicine News:Health News:NAMI Launches New PSA Campaign 2Health News:St. Charles Surgical Hospital Announces Dedicated Lymphedema Treatment Program 2Health News:St. Charles Surgical Hospital Announces Dedicated Lymphedema Treatment Program 3Health News:Cox Movies Under the Moon(R) Offers Big-Screen Hits Under the Stars 2Health News:Cox Movies Under the Moon(R) Offers Big-Screen Hits Under the Stars 3Health News:Almost Quarter of Suicides Involve Intoxication 2Health News:U.S. News & World Report Ranks Children's National Medical Center among Best Children's Hospitals 2Health News:U.S. News & World Report Ranks Children's National Medical Center among Best Children's Hospitals 3
... Detect™ IgM Capture ELISA is for the ... WNV recombinant antigens (WNRA) in serum as ... of West Nile virus infection in patients ... results must be confirmed by Plaque Reduction ...
Adult; dilates 6.0 to 34.0 French; individually packaged, sterile....
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: